Tyrosinemia type I is attributed to a mutation in the fumarylacetoacetate hydrolase gene (Fah-/-), and it is known that a loss/mutation in the homogentisic acid dioxygenase (Hgd) gene located on chromosome 16 is protective against this disease. Here, FAH is linked to tyrosinemia type I.